Clinical Trial Update: Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease

View source ↗

Summary

This clinical trial update reports long-term safety and efficacy data for pasireotide subcutaneous in patients with Cushing's disease. The study is completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease

Drugs mentioned

• SIGNIFOR (PASIREOTIDE)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Cushings Disease | Status: COMPLETED | Results posted: 2024-10-15